Exceptional Genetics, Generalizable Therapeutics, and Coronary Artery Disease (Posted May 30, 2024 0PM)

https://phgkb.cdc.gov/PHGKB/specificPHGKB.action?topic=HLBS&query=home From the article: "The increasingly widespread availability of genomic sequencing has enabled the identification of persons and families with uniquely favorable traits, including a very low incidence of clinical events. Such exceptional persons across diverse communities are playing an important role in the genesis of medicines for common cardiovascular diseases. "